Range
18.6 - 19.11
Vol / Avg.
418.6K/483.7K
Div / Yield
-
52 Wk
13.02 - 27.85
Mkt Cap
905M
Payout Ratio
-
Open
19.02
P/E
-
EPS
-0.44
Shares
48.6M
Outstanding
48.6M
Total Float
47.7M
load more
Sector: Health Care.Industry: Biotechnology
Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-09
REV
Q2 2021Est.ActualSurprise
EPS-0.710-0.440 0.2700
REV220.000K379.000K159.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Syndax Pharmaceuticals Questions & Anwsers

Q

How do I buy Syndax Pharmaceuticals (SNDX) stock?

A

You can purchase shares of Syndax Pharmaceuticals (NASDAQ: SNDX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Syndax Pharmaceuticals's (SNDX) competitors?

Q

What is the target price for Syndax Pharmaceuticals (SNDX) stock?

A

The latest price target for Syndax Pharmaceuticals (NASDAQ: SNDX) was reported by Morgan Stanley on October 12, 2021. The analyst firm set a price target for 21.00 expecting SNDX to rise to within 12 months (a possible 12.84% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Syndax Pharmaceuticals (SNDX)?

A

The stock price for Syndax Pharmaceuticals (NASDAQ: SNDX) is $18.61 last updated Wed Oct 27 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Syndax Pharmaceuticals (SNDX) pay a dividend?

A

There are no upcoming dividends for Syndax Pharmaceuticals.

Q

When is Syndax Pharmaceuticals (NASDAQ:SNDX) reporting earnings?

A

Syndax Pharmaceuticals’s $Q3 earnings are confirmed for after-market on $November 9, 2021.

Q

Is Syndax Pharmaceuticals (SNDX) going to split?

A

There is no upcoming split for Syndax Pharmaceuticals.

Q

What sector and industry does Syndax Pharmaceuticals (SNDX) operate in?

A

Syndax Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.